Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translation
暂无分享,去创建一个
[1] Jorge Sepulcre,et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease , 2016, Annals of neurology.
[2] S. Leurgans,et al. Hippocampal sclerosis and TDP‐43 pathology in aging and Alzheimer disease , 2015, Annals of neurology.
[3] Bradford C. Dickerson,et al. Tau PET imaging in aging and early Alzheimer's disease , 2015 .
[4] Anirvan Ghosh,et al. Specification of synaptic connectivity by cell surface interactions , 2015, Nature Reviews Neuroscience.
[5] Veronica Redaelli,et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis , 2015, The Lancet Neurology.
[6] A. Jeromin,et al. Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment. , 2015, JAMA neurology.
[7] E. Mandelkow,et al. Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.
[8] S. Leurgans,et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.
[9] Michel Goedert,et al. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein , 2015, Science.
[10] Ann C. McKee,et al. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy , 2015, Nature.
[11] Andrew J. Lees,et al. Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy , 2011, Nature Genetics.
[12] C. Heyser,et al. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis , 2015, Neuron.